Literature DB >> 15626878

Techniques for uretero-intestinal reimplantation.

Christoph Wiesner1, Joachim W Thüroff.   

Abstract

PURPOSE OF REVIEW: Uretero-intestinal reimplantation is a crucial component of urinary diversion. Several techniques for refluxing and nonrefluxing uretero-intestinal reimplantation have been established and modified to minimize anastomotic complications and preserve renal function. We review current experience with uretero-intestinal reimplantation in different types of urinary diversion. RECENT
FINDINGS: The basic principles of uretero-intestinal reimplantation are still controversially discussed. Several studies have focused on complications of urinary reflux from direct end-to-side or end-to-end anastomosis, such as pyelonephritis and calculus formation. Strictures at the anastomotic site of nonrefluxing tunneled ureteral reimplantation resulting in hydronephrosis and renal deterioration have led some to question the need for an antirefluxive anastomosis, at least in "low pressure urinary diversion". Alternative surgical procedures aim to avoid reflux and minimize the risk for anastomotic strictures by direct ureteral reimplantation into an intact isoperistaltic afferent ileal segment or the prevalvular ileum, with the ileocaecal valve functioning as an antireflux mechanism.
SUMMARY: A "gold standard" for uretero-intestinal anastomosis in urinary diversion does not yet exist. Further prospective randomized studies are required to identify the best anastomotic techniques for different types of urinary diversion.

Entities:  

Mesh:

Year:  2004        PMID: 15626878     DOI: 10.1097/00042307-200411000-00010

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  1 in total

1.  Vacuum-assisted closure therapy in ureteroileal anastomotic leakage after surgical therapy of bladder cancer.

Authors:  Stefan Denzinger; Lars Luebke; Maximilian Burger; Sigurd Kessler; Wolf F Wieland; Wolfgang Otto
Journal:  World J Surg Oncol       Date:  2007-04-12       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.